Products
Chemical Compositions
Provide pharmaceutical companies with customized research and development, process optimization, and large-scale production services for pharmaceutical intermediates.
Products
| Therapeutics Area | CAS No. | Intermediate Name | API |
|---|---|---|---|
| Antivirals | 1620056-47-4 | Carbamic acid, N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester | lenacapavir |
| Antivirals | 2189684-54-4 | Carbamic acid,N-[(1S)-1-[3-bromo-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-,1,1-dimethylethyl ester | lenacapavir |
| Antivirals | 2189684-53-3 | 1H-Indazol-3-amine, 4-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)- | lenacapavir |
| Antivirals | 1620056-83-8 | 1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetic acid, 5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)- | lenacapavir |
| Antivirals | 2109226-54-0 | 3-Methyl-3-(methylsulfonyl)but-1-yne | lenacapavir |
| Antivirals | 2375019-85-3 | 2-Pyridinemethanamine, 3-bromo-α-[(3,5-difluorophenyl)methyl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-, (αS)- | lenacapavir |
| Antivirals | 2375020-20-3 | N-((S)-1-(3-(3-amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide | lenacapavir |
| Antivirals | 2189684-44-2 | GS-6207 | lenacapavir |
| Antivirals | 2375020-20-3 | N-((S)-1-(3-(3-amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide | lenacapavir |
| Antivirals | 1155846-86-8 | Benzonitrile, 3-chloro-5-[[1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]- | Doravirine |
| Antivirals | 861347-86-6 | 3-Chloro-5-iodophenol | Doravirine |
| Antivirals | 142217-80-9 | 6-(benzyloxy)-9-((1s,3r,3s)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-n-((4-methoxyphenyl)diphenylmethyl)-9h-purin-2-amine | Entecavir |
| GLP-1 | 1784678-61-0 | 5-Bromo-4-fluoro-1-methyl-1H-indazole | Orforglipron |
| GLP-1 | 174953-30-1 | (S)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide | Orforglipron |
| GLP-1 | 2212021-40-2 | (4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride | Orforglipron |
| GLP-1 | 7254-19-5 | 5-Bromoindole-2-carboxylic acid | Orforglipron |
| GLP-1 | 1073666-54-2 | (S)-3-Aminobutanenitrile hydrochloride | Orforglipron |
| GLP-1 | 1082041-85-7 | 5-bromo-4-fluoro-1H-indazole | Orforglipron |
| Anti-cancer | 2738675-96-0 | (R)-3-FLUORO-5-((3-HYDROXY-7-(METHYLSULFONYL)-1-OXO-2,3-DIHYDRO-1H-INDEN-4-YL)OXY)BENZONITRILE | Belzutifan |
| Anti-cancer | 1672665-55-2 | Benzonitrile, 3-[[2,3-dihydro-7-(methylsulfonyl)-1-oxo-1H-inden-4-yl]oxy]-5-fluoro- | Belzutifan |
Chemical Reaction
We have been working on continuous flow chemistry for many years. We have achieved a full-chain R&D capability, from designing reaction devices to chemical processes, with mature reaction technologies.
Device
We have multifunctional production sites:
Site for R&D, pharmaceutical intermediates, and new materials.
Site for pharmaceutical starting materials, advanced intermediates, and high-performance materials.
Multifunctional production platform for advanced intermediates and APIs.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →